The ATS 3f aortic bioprosthesis

James L. Cox

doi:10.1007/978-3-7985-1869-8_27

The ATS 3f aortic bioprosthesis

James L. Cox

Department of Surgery

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

1 Scopus citations

Abstract

Artificial tissue valves are less durable than artificial mechanical valves but they require less anticoagulation than mechanical valves and, thus, are associated with fewer bleeding complications. The past 40 years have witnessed persistent efforts to manufacture either a mechanical valve that does not require warfarin therapy or a tissue valve with greater long-term durability. The ATS 3f Aortic Bioprosthesis was developed specifically to address the durability problem with previously designed artificial tissue valves.

Original language	English
Title of host publication	Aortic Root Surgery
Subtitle of host publication	The Biological Solution
Publisher	Steinkopff
Pages	386-395
Number of pages	10
ISBN (Print)	9783798518681
DOIs	https://doi.org/10.1007/978-3-7985-1869-8_27
State	Published - Dec 1 2010

Access to Document

10.1007/978-3-7985-1869-8_27

Cite this

@inbook{95da296e840144bfbd1dbfdb206ca09a,

title = "The ATS 3f aortic bioprosthesis",

abstract = "Artificial tissue valves are less durable than artificial mechanical valves but they require less anticoagulation than mechanical valves and, thus, are associated with fewer bleeding complications. The past 40 years have witnessed persistent efforts to manufacture either a mechanical valve that does not require warfarin therapy or a tissue valve with greater long-term durability. The ATS 3f Aortic Bioprosthesis was developed specifically to address the durability problem with previously designed artificial tissue valves.",

author = "Cox, {James L.}",

year = "2010",

month = dec,

day = "1",

doi = "10.1007/978-3-7985-1869-8_27",

language = "English",

isbn = "9783798518681",

pages = "386--395",

booktitle = "Aortic Root Surgery",

publisher = "Steinkopff",

}

TY - CHAP

T1 - The ATS 3f aortic bioprosthesis

AU - Cox, James L.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Artificial tissue valves are less durable than artificial mechanical valves but they require less anticoagulation than mechanical valves and, thus, are associated with fewer bleeding complications. The past 40 years have witnessed persistent efforts to manufacture either a mechanical valve that does not require warfarin therapy or a tissue valve with greater long-term durability. The ATS 3f Aortic Bioprosthesis was developed specifically to address the durability problem with previously designed artificial tissue valves.

AB - Artificial tissue valves are less durable than artificial mechanical valves but they require less anticoagulation than mechanical valves and, thus, are associated with fewer bleeding complications. The past 40 years have witnessed persistent efforts to manufacture either a mechanical valve that does not require warfarin therapy or a tissue valve with greater long-term durability. The ATS 3f Aortic Bioprosthesis was developed specifically to address the durability problem with previously designed artificial tissue valves.

UR - http://www.scopus.com/inward/record.url?scp=80051570966&partnerID=8YFLogxK

U2 - 10.1007/978-3-7985-1869-8_27

DO - 10.1007/978-3-7985-1869-8_27

M3 - Chapter

AN - SCOPUS:80051570966

SN - 9783798518681

SP - 386

EP - 395

BT - Aortic Root Surgery

PB - Steinkopff

ER -

The ATS 3f aortic bioprosthesis

Abstract

Access to Document

Other files and links

Fingerprint

Cite this